{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:54:10Z","timestamp":1792716850742,"version":"4.5.0"},"reference-count":255,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.yjmcc.2015.02.025","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T05:51:45Z","timestamp":1425621105000},"page":"73-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":131,"special_numbering":"C","title":["Heart failure with preserved ejection fraction in the elderly: scope of the problem"],"prefix":"10.1016","volume":"83","author":[{"given":"Bharathi","family":"Upadhya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E.","family":"Taffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che Ping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalane W.","family":"Kitzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2015.02.025_bb0005","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0735-1097(00)00582-9","article-title":"Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study","volume":"35","author":"Gottdiener","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.080770","article-title":"Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction: Prevalence, Therapies, and Outcomes","volume":"126","author":"Steinberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/archinte.166.1.112","article-title":"Costs for Heart Failure With Normal vs Reduced Ejection Fraction","volume":"166","author":"Liao","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0030","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure: A Report From the OPTIMIZE-HF Registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0035","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/CIRCHEARTFAILURE.112.968594","article-title":"Comorbidity and Ventricular and Vascular Structure and Function in Heart Failure With Preserved Ejection Fraction\/Clinical Perspective","volume":"5","author":"Mohammed","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0040","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/01.CIR.101.17.2118","article-title":"Defining diastolic heart failure: a call for standardized diagnostic criteria","volume":"101","author":"Vasan","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM200101043440103","article-title":"The Pathogenesis of Acute Pulmonary Edema Associated with Hypertension","volume":"344","author":"Gandhi","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0050","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/hc3201.094226","article-title":"Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?","volume":"104","author":"Zile","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0055","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa032566","article-title":"Diastolic heart failure\u2013abnormalities in active relaxation and passive stiffness of the left ventricle","volume":"350","author":"Zile","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0060","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/01.CIR.0000048123.22359.A0","article-title":"Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction","volume":"107","author":"Kawaguchi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0070","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","article-title":"Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction","volume":"131","author":"Mohammed","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0075","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/CIRCULATIONAHA.114.014420","article-title":"What the dead can teach the living: the systemic nature of heart failure with preserved ejection fraction","volume":"131","author":"Kitzman","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0080","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.CIR.0000053947.82595.03","article-title":"Heart failure with a normal ejection fraction: is it really a disorder of diastolic function?","volume":"107","author":"Burkhoff","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1315","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"ACCF\/AHA Guideline for the management of heart-failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0090","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0095","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(12)61227-6","article-title":"The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial","volume":"380","author":"Solomon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jacc.2013.10.007","article-title":"Heart failure with preserved ejection fraction: a heterogenous disorder with multifactorial pathophysiology","volume":"63","author":"Kitzman","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0105","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/hc1102.105289","article-title":"New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function","volume":"105","author":"Zile","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0110","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jacc.2006.08.050","article-title":"Cardiovascular Features of Heart Failure With Preserved Ejection Fraction Versus Nonfailing Hypertensive Left Ventricular Hypertrophy in the Urban Baltimore Community: The Role of Atrial Remodeling\/Dysfunction","volume":"49","author":"Melenovsky","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0115","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jacc.2011.02.054","article-title":"Heart Failure With a Preserved Ejection Fraction: What Is in a Name?","volume":"58","author":"Maurer","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/HCR.0b013e3181d0c1ad","article-title":"Cardiopulmonary exercise testing variables reflect the degree of diastolic dysfunction in patients with heart failure-normal ejection fraction","volume":"30","author":"Guazzi","year":"2010","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0125","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","article-title":"Heart Disease and Stroke Statistics \u20132011 update: a report from the American Heart Association","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0002-9149(00)01393-X","article-title":"Importance of heart failure with preserved systolic function in patients > or = 65 Years of Age. CHS Research Group. Cardiovascular Health Study","volume":"87","author":"Kitzman","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0135","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0735-1097(99)00118-7","article-title":"Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort","volume":"33","author":"Vasan","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0140","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","article-title":"Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database","volume":"47","author":"Yancy","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0145","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/eurheartj\/ehm554","article-title":"Prognosis of heart failure with preserved ejection fraction: a 5year prospective population-based study","volume":"29","author":"Tribouilloy","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0150","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/eurheartj\/ehr254","article-title":"The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis","volume":"33","author":"Meta-analysis Global Group","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0155","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of Noncardiac Comorbidities on Morbidity and Mortality in a Predominantly Male Population With Heart Failure and Preserved Versus Reduced Ejection Fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0160","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1016\/S0735-1097(12)60853-5","volume":"59","author":"Gottdiener","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0165","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","article-title":"Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment","volume":"32","author":"Borlaug","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0170","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/CIRCULATIONAHA.105.541078","article-title":"Age- and gender-related ventricular-vascular stiffening: a community-based study","volume":"112","author":"Redfield","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0175","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fphys.2013.00396","article-title":"Beta-adrenergic receptor responsiveness in aging heart and clinical implications","volume":"4","author":"Ferrara","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0180","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","article-title":"Epidemiology of heart failure","volume":"113","author":"Roger","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0185","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/eurheartj\/eht555","article-title":"The Year in Cardiology 2013: heart failure","volume":"35","author":"Ertl","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0190","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/CIRCRESAHA.111.246876","article-title":"The intersection between aging and cardiovascular disease","volume":"110","author":"North","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0195","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/01.CIR.0000048894.99865.02","article-title":"Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging","volume":"107","author":"Lakatta","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0200","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/01.CIR.0000048893.62841.F7","article-title":"Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease","volume":"107","author":"Lakatta","year":"2003","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.yjmcc.2015.02.025_bb0205","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1089\/ars.2011.4179","article-title":"Cardiac aging: from molecular mechanisms to significance in human health and disease","volume":"16","author":"Dai","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0210","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCRESAHA.113.302254","article-title":"Research advances in heart failure: a compendium","volume":"113","author":"Braunwald","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0215","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/CIRCRESAHA.113.300309","article-title":"Integrating the myocardial matrix into heart failure recognition and management","volume":"113","author":"Spinale","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0220","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/CIRCHEARTFAILURE.110.958785","article-title":"Exercise training in older patients with heart failure and preserved ejection fraction","volume":"3","author":"Kitzman","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0225","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCHEARTFAILURE.113.000383","article-title":"Longitudinal changes in left ventricular stiffness: a community-based study","volume":"6","author":"Borlaug","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0230","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jchf.2014.03.014","article-title":"Impact of general and central adiposity on ventricular-arterial aging in women and men","volume":"2","author":"Wohlfahrt","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0235","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1161\/01.CIR.102.12.1351","article-title":"Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men","volume":"102","author":"DeSouza","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0240","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/01.HYP.27.4.849","article-title":"Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans","volume":"27","author":"Gerhard","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0245","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacc.2010.03.077","article-title":"Global Cardiovascular Reserve Dysfunction in Heart Failure With Preserved Ejection Fraction","volume":"56","author":"Borlaug","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0250","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cardfail.2007.04.010","article-title":"Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of vetalloproteinases (TIMPs)","volume":"13","author":"Bonnema","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0255","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","article-title":"Transforming growth factor (TGF)-beta signaling in cardiac remodeling","volume":"51","author":"Dobaczewski","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0260","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","article-title":"The role of TGF-beta signaling in myocardial infarction and cardiac remodeling","volume":"74","author":"Bujak","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0265","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2362.2002.00985.x","article-title":"Myocardial fibrosis in transforming growth factor-beta (1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase","volume":"32","author":"Seeland","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0270","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/01.CIR.0000020689.12472.E0","article-title":"Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats","volume":"106","author":"Kuwahara","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0275","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/jmcc.1999.1065","article-title":"Myocardial fibrosis in transforming growth factor beta(1) heterozygous mice","volume":"32","author":"Brooks","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0280","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/0735-1097(95)00282-8","article-title":"Gender differences and aging: effects on the human heart","volume":"26","author":"Olivetti","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0285","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.exger.2011.02.010","article-title":"Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy","volume":"46","author":"Boyle","year":"2011","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0290","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A Novel Paradigm for Heart Failure with Preserved Ejection Fraction: Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0295","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physiolgenomics.00136.2003","article-title":"Proinflammatory phenotype of coronary arteries promotes endothelial apoptosis in aging","volume":"17","author":"Csiszar","year":"2004","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0300","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2353\/ajpath.2007.060708","article-title":"Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging","volume":"170","author":"Csiszar","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0305","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.RES.0000187457.24338.3D","article-title":"NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts","volume":"97","author":"Cucoranu","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0310","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tcm.2009.12.004","article-title":"Cardiac aging in mice and humans: the role of mitochondrial oxidative stress","volume":"19","author":"Dai","year":"2009","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0315","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature02517","article-title":"Premature ageing in mice expressing defective mitochondrial DNA polymerase","volume":"429","author":"Trifunovic","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0320","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ng.95","article-title":"DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice","volume":"40","author":"Vermulst","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0325","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/ng1988","article-title":"Mitochondrial point mutations do not limit the natural lifespan of mice","volume":"39","author":"Vermulst","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0330","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4161\/auto.6.5.11947","article-title":"Inhibition of autophagy in the heart induces age-related cardiomyopathy","volume":"6","author":"Taneike","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0335","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1089\/ars.2009.2598","article-title":"Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging","volume":"12","author":"Terman","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0340","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCRESAHA.110.232306","article-title":"Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure","volume":"108","author":"Dai","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0345","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jacc.2010.12.044","article-title":"Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy","volume":"58","author":"Dai","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0350","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1161\/01.RES.0000012569.55432.02","article-title":"Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide\/cGMP signaling","volume":"90","author":"Mollnau","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0355","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.192.7.1001","article-title":"Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes","volume":"192","author":"Zorov","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0360","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1172\/JCI1335","article-title":"Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases","volume":"101","author":"Xiao","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0365","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1013797722156","article-title":"Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons","volume":"7","author":"Lakatta","year":"2002","journal-title":"Heart Fail Rev"},{"issue":"5","key":"10.1016\/j.yjmcc.2015.02.025_bb0370","first-page":"453","article-title":"Age-associated changes in Ca(2+)-ATPase and oxidative damage in sarcoplasmic reticulum of rat heart","volume":"61","author":"Babusikova","year":"2012"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0375","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1161\/CIRCRESAHA.110.217570","article-title":"Oxidative posttranslational modifications mediate decreased SERCA activity and myocyte dysfunction in Galphaq-overexpressing mice","volume":"107","author":"Lancel","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0380","doi-asserted-by":"crossref","first-page":"e000184","DOI":"10.1161\/JAHA.113.000184","article-title":"Hydrogen peroxide-mediated SERCA cysteine 674 oxidation contributes to impaired cardiac myocyte relaxation in senescent mouse heart","volume":"2","author":"Qin","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0385","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/01.HYP.21.4.498","article-title":"Age and gender influence muscle sympathetic nerve activity at rest in healthy humans","volume":"21","author":"Ng","year":"1993","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0390","first-page":"R278","article-title":"Aging effects on human sympathetic neuronal function","volume":"268","author":"Esler","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0395","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fphys.2013.00324","article-title":"Adrenergic signaling and oxidative stress: a role for sirtuins?","volume":"4","author":"Corbi","year":"2013","journal-title":"Front Physiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0400","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.exger.2006.05.008","article-title":"Exercise training affects age-induced changes in SOD and heat shock protein expression in rat heart","volume":"41","author":"Rinaldi","year":"2006","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0405","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/728547","article-title":"Is physical activity able to modify oxidative damage in cardiovascular aging?","volume":"2012","author":"Corbi","year":"2012","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0410","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2741\/e417","article-title":"Role of sirtuins, calorie restriction and physical activity in aging","volume":"4","author":"Corbi","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0415","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cardiores.2005.02.012","article-title":"Sympathetic neuronal regulation of the heart in aging and heart failure","volume":"66","author":"Kaye","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0420","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.CIR.91.2.351","article-title":"Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors","volume":"91","author":"Esler","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0425","doi-asserted-by":"crossref","first-page":"H259","DOI":"10.1152\/ajpheart.1989.257.1.H259","article-title":"Morphological and contractile characteristics of rat cardiac myocytes from maturation to senescence","volume":"257","author":"Fraticelli","year":"1989","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0430","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.hfc.2007.07.004","article-title":"Epidemiology, pathophysiology, and prognosis of heart failure in the elderly","volume":"3","author":"Thomas","year":"2007","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0435","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1631\/jzus.B0820213","article-title":"Expressions of cardiac sympathetic norepinephrine transporter and beta1-adrenergic receptor decreased in aged rats","volume":"10","author":"Li","year":"2009","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0440","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.cardfail.2011.06.217","article-title":"Genotype and phenotypic characteristics of persons with cardiac smyloidosis from the Multinational Transthyretin Amyloidosis Outcomes Survey (THAOS) Registry","volume":"17","author":"Dharmarajan","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0445","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCHEARTFAILURE.109.910455","article-title":"Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS)","volume":"4","author":"Bhuiyan","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0450","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types","volume":"120","author":"Rapezzi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0455","article-title":"Cardiac amyloid deposition is common in elderly patients with heart failure and preserved ejection fraction","volume":"122","author":"Mirzoyev","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0460","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","article-title":"Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction","volume":"2","author":"Mohammed","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0465","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1111444","article-title":"Ribo-gnome: the big world of small RNAs","volume":"309","author":"Zamore","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0470","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.RES.0000257913.42552.23","article-title":"MicroRNAs play an essential role in the development of cardiac hypertrophy","volume":"100","author":"Sayed","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0475","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature11919","article-title":"MicroRNA-34a regulates cardiac ageing and function","volume":"495","author":"Boon","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0480","first-page":"565","article-title":"microRNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2","volume":"7","author":"Dong","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0485","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIRCULATIONAHA.106.659763","article-title":"Cardiac Structure and Ventricular Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota","volume":"115","author":"Lam","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0490","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jacc.2009.05.013","article-title":"Contractility and Ventricular Systolic Stiffening in Hypertensive Heart Disease: Insights Into the Pathogenesis of Heart Failure With Preserved Ejection Fraction","volume":"54","author":"Borlaug","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0495","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1161\/CIRCULATIONAHA.110.011031","article-title":"Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction","volume":"124","author":"Zile","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0500","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jacc.2006.10.061","article-title":"Ventricular Structure and Function in Hypertensive Participants With Heart Failure and a Normal Ejection Fraction: The Cardiovascular Health Study","volume":"49","author":"Maurer","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0505","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/HYPERTENSIONAHA.109.138529","article-title":"Effect of Intensive Versus Standard Blood Pressure Lowering on Diastolic Function in Patients With Uncontrolled Hypertension and Diastolic Dysfunction","volume":"55","author":"Solomon","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0510","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1161\/CIRCULATIONAHA.105.587519","article-title":"Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure","volume":"113","author":"van Heerebeek","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0515","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jcmg.2014.04.022","article-title":"CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF","volume":"7","author":"Su","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0520","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1305","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: The aldo-dhf randomized controlled trial","volume":"309","author":"Edelmann","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0530","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0535","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1093\/eurheartj\/ehp341","article-title":"Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure","volume":"30","author":"Wachter","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0540","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/hrt.2010.212787","article-title":"Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction","volume":"97","author":"Borlaug","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0545","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jacc.2009.03.037","article-title":"The Pathophysiology of Heart Failure With Normal Ejection Fraction: Exercise Echocardiography Reveals Complex Abnormalities of Both Systolic and Diastolic Ventricular Function Involving Torsion, Untwist, and Longitudinal Motion","volume":"54","author":"Tan","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0550","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jacc.2009.05.012","article-title":"Heart Failure With Preserved Ejection Fraction Is Characterized by Dynamic Impairment of Active Relaxation and Contraction of the Left Ventricle on Exercise and Associated With Myocardial Energy Deficiency","volume":"54","author":"Phan","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0555","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/hrt.2009.185181","article-title":"Abnormal left ventricular function occurs on exercise in well-treated hypertensive subjects with normal resting echocardiography","volume":"96","author":"Tan","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0560","first-page":"72","article-title":"Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism","volume":"8","author":"Kitzman","year":"1991","journal-title":"Cardiol Board Rev"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0565","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jcmg.2012.05.013","article-title":"Loss of adrenergic augmentation of diastolic intra-LV pressure difference in patients with diastolic dysfunction: evaluation by color M-mode echocardiography","volume":"5","author":"Ohara","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0570","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cvr\/27.3.341","article-title":"Myocardial fibrosis: functional significance and regulatory factors","volume":"27","author":"Weber","year":"1993","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0575","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1161\/CIRCULATIONAHA.105.573865","article-title":"Matrix Metalloproteinases\/Tissue Inhibitors of Metalloproteinases: Relationship Between Changes in Proteolytic Determinants of Matrix Composition and Structural, Functional, and Clinical Manifestations of Hypertensive Heart Disease","volume":"113","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0585","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","article-title":"Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction","volume":"2","author":"Mohammed","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0590","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.RES.58.2.281","article-title":"Regulation of stroke volume during submaximal and maximal upright exercise in normal man","volume":"58","author":"Higginbotham","year":"1986","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0600","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/CIRCHEARTFAILURE.109.877720","article-title":"Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction","volume":"3","author":"Phan","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0605","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00008483-200603000-00007","article-title":"Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients","volume":"26","author":"Brubaker","year":"2006","journal-title":"J Cardiopulm Rehabil"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0610","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jacc.2011.02.055","article-title":"Determinants of Exercise Intolerance in Elderly Heart Failure Patients With Preserved Ejection Fraction","volume":"58","author":"Haykowsky","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0615","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1161\/CIRCULATIONAHA.110.940577","article-title":"Chronotropic Incompetence: Causes, Consequences, and Management","volume":"123","author":"Brubaker","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0620","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199910283411804","article-title":"Heart-Rate Recovery Immediately after Exercise as a Predictor of Mortality","volume":"341","author":"Cole","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0625","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure with Preserved Ejection Fraction","volume":"3","author":"Borlaug","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0630","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0735-1097(91)90832-T","article-title":"Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism","volume":"17","author":"Kitzman","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0635","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.106.632745","article-title":"Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction","volume":"114","author":"Borlaug","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0640","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cardfail.2008.02.012","article-title":"Left Ventricular Abnormal Response During Dynamic Exercise in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction at Rest","volume":"14","author":"Ennezat","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0650","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/eurjhf\/hft026","article-title":"Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction","volume":"15","author":"Abudiab","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0655","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/hc1002.105185","article-title":"Progression of systolic abnormalities in patients with \"isolated\" diastolic heart failure and diastolic dysfunction","volume":"105","author":"Yu","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0660","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jacc.2013.09.052","article-title":"Impaired Systolic Function by Strain Imaging in Heart Failure with Preserved Ejection Fraction","volume":"63","author":"Kraigher-Krainer","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0670","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jacc.2011.10.873","article-title":"Increased Proximal Arterial Stiffness and Cardiac Response With Moderate Exercise in Patients With Heart Failure and Preserved Ejection Fraction","volume":"59","author":"Tartiere-Kesri","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0675","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0735-1097(01)01447-4","article-title":"Cardiac cycle-dependent changes in aortic area and aortic distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance","volume":"38","author":"Hundley","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0680","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/HYPERTENSIONAHA.111.00163","article-title":"Carotid arterial stiffness and its relationship to exercise intolerance in older patients with heart failure and preserved ejection fraction","volume":"61","author":"Kitzman","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0685","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1532-429X-11-48","article-title":"Reduced peripheral arterial blood flow with preserved cardiac output during submaximal bicycle exercise in elderly heart failure","volume":"11","author":"Puntawangkoon","year":"2009","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0690","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/gerona\/gls099","article-title":"Relationship of flow mediated arterial; dilation and exercise capacity in older patients with heart failure and preserved ejection fraction","volume":"68","author":"Haykowsky","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0695","doi-asserted-by":"crossref","first-page":"H1427","DOI":"10.1152\/ajpheart.00567.2006","article-title":"Leg flow-mediated arterial dilation in elderly patients with heart failure and normal left ventricular ejection fraction","volume":"292","author":"Hundley","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0700","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2012.09.021","article-title":"Endothelial dysfunction measured by peripheral arterial tonometry predicts prognosis in patients with heart failure with preserved ejection fraction","volume":"168","author":"Matsue","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0705","doi-asserted-by":"crossref","first-page":"H1364","DOI":"10.1152\/ajpheart.00004.2014","article-title":"Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction","volume":"306","author":"Kitzman","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0710","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.HYP.0000249510.20326.72","article-title":"Hypertension: a disease of the microcirculation?","volume":"48","author":"Feihl","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0715","doi-asserted-by":"crossref","first-page":"I31","DOI":"10.1161\/CIRCULATIONAHA.106.680157","article-title":"Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes","volume":"116","author":"Boodhwani","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0720","doi-asserted-by":"crossref","first-page":"e99495","DOI":"10.1371\/journal.pone.0099495","article-title":"Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology","volume":"9","author":"Putko","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0725","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0735-1097(03)00956-2","article-title":"The left atrium: a biomarker of chronicdiastolic dysfunction andcardiovascular disease risk","volume":"42","author":"Douglas","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0730","first-page":"881","article-title":"Left atrium: no longer neglected","volume":"6","author":"Rossi","year":"2005","journal-title":"Ital Heart J"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0735","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ahj.2008.07.021","article-title":"Echocardiographic evaluation of left atrial size and function: current understanding, pathophysiologic correlates, and prognostic implications","volume":"156","author":"Leung","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0740","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.amjcard.2005.05.031","article-title":"Usefulness of left atrial volume in predicting first congestive heart failure in patients>=65years of age with well-preserved left ventricular systolic function","volume":"96","author":"Takemoto","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0745","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology","volume":"28","author":"Paulus","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0755","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1136\/hrt.2009.189118","article-title":"Reduced left atrial function on exercise in patients with heart failure and normal ejection fraction","volume":"96","author":"Tan","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0760","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCIMAGING.108.813071","article-title":"Left atrial function in diastolic heart failure","volume":"2","author":"Kurt","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0765","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/eurjhf\/hfr169","article-title":"Atrial dyssynchrony syndrome: an overlooked phenomenon and a potential cause of 'diastolic' heart failure","volume":"14","author":"Eicher","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0770","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.114.001667","article-title":"Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction","author":"Melenovsky","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0775","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cardfail.2007.04.014","article-title":"Impact of atrial fibrillation in heart failure with normal ejection fraction: a clinical and cchocardiographic study","volume":"13","author":"Fung","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0780","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.113.001475","article-title":"Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study","volume":"128","author":"Zakeri","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0785","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/CIRCHEARTFAILURE.113.000568","article-title":"Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study","volume":"7","author":"Zakeri","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0790","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2008.11.051","article-title":"Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Community-Based Study","volume":"53","author":"Lam","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0795","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/CIRCULATIONAHA.111.085761","article-title":"Pulmonary hypertension due to left heart disease","volume":"126","author":"Guazzi","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0800","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1161\/CIRCULATIONAHA.108.838698","article-title":"Age-associated increases in pulmonary artery systolic pressure in the general population","volume":"119","author":"Lam","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0805","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurjhf\/hfn013","article-title":"Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology","volume":"11","author":"Hawkins","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0810","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jacc.2011.09.062","article-title":"Effects of Vasodilation in Heart Failure With Preserved or Reduced Ejection Fraction: Implications of Distinct Pathophysiologies on Response to Therapy","volume":"59","author":"Schwartzenberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0815","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1093\/eurheartj\/ehu193","article-title":"Right heart dysfunction in heart failure with preserved ejection fraction","volume":"35","author":"Melenovsky","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0820","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1161\/CIRCULATIONAHA.113.008461","article-title":"Right ventricular function in heart failure with preserved ejection fraction: a community-based study","volume":"130","author":"Mohammed","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0825","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.hlc.2013.03.072","article-title":"Right ventricular function in left ventricular disease: pathophysiology and implications","volume":"22","author":"Schwarz","year":"2013","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0830","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.jacc.2011.07.042","article-title":"Impaired natriuretic and renal endocrine response to acute volume expansion in pre-clinical systolic and diastolic dysfunction","volume":"58","author":"McKie","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0835","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1751-7133.2010.00208.x","article-title":"Blood volume measurements in patients with heart failure and a preserved ejection fraction: implications for diagnosing anemia","volume":"17","author":"Noumi","year":"2011","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0840","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10741-011-9261-3","article-title":"Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome","volume":"17","author":"Colombo","year":"2012","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0845","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2013.07.010","article-title":"Matchmaking for the optimization of clinical trials of heart failure with preserved ejection fraction: no laughing matter","volume":"62","author":"Shah","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0850","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/eurjhf\/hfr133","article-title":"Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction","volume":"13","author":"Bhella","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0855","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1152\/jappl.2000.88.6.2138","article-title":"Near-maximal fractional oxygen extraction by active skeletal muscle in patients with chronic heart failure","volume":"88","author":"Katz","year":"2000","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0860","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1001\/jama.288.17.2144","article-title":"Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure","volume":"288","author":"Kitzman","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0865","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2010.04.040","article-title":"Hemodynamic Basis of Exercise Limitation in Patients With Heart Failure and Normal Ejection Fraction","volume":"56","author":"Maeder","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0870","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11897-012-0087-7","article-title":"Role of Physical Training in Heart Failure with Preserved Ejection Fraction","volume":"9","author":"Haykowsky","year":"2012","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0875","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jacc.2012.02.055","article-title":"Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction","volume":"60","author":"Haykowsky","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0880","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCHEARTFAILURE.114.001615","article-title":"Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials","volume":"8","author":"Pandey","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0885","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.exger.2011.10.001","article-title":"Age-related differences in lower extremity tissue compartments and associations with physical function in older adults","volume":"47","author":"Buford","year":"2012","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0890","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/clnu.2001.0485","article-title":"The contribution of starvation, deconditioning and ageing to the observed alterations in peripheral skeletal muscle in chronic organ diseases","volume":"21","author":"Franssen","year":"2002","journal-title":"Clin Nutr"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0895","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1136\/hrt.72.2_Suppl.S36","article-title":"Symptoms and quality of life in heart failure: the muscle hypothesis","volume":"72","author":"Coats","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0900","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/CIRCHEARTFAILURE.109.903773","article-title":"Making the Case for Skeletal Myopathy as the Major Limitation of Exercise Capacity in Heart Failure","volume":"3","author":"Middlekauff","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0905","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3945\/ajcn.112.047860","article-title":"Associations between body composition and gait-speed decline: results from the Health, Aging, and Body Composition study","volume":"97","author":"Beavers","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0910","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCULATIONAHA.107.716662","article-title":"Tipping the Scale: Heart Failure, Body Mass Index, and Prognosis","volume":"116","author":"von Haehling","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0915","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0735-1097(97)00381-1","article-title":"Skeletal muscle function and its relation to exercise tolerance in chronic heart failure","volume":"30","author":"Harrington","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0920","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0140-6736(96)07015-8","article-title":"Wasting as independent risk factor for mortality in chronic heart failure","volume":"349","author":"Anker","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0925","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","article-title":"Sarcopenia: an undiagnosed condition in older adults. Current donsensus definition: prevalence, etiology, and consequences. International Working Group on Sarcopenia","volume":"12","author":"Fielding","year":"2011","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0930","doi-asserted-by":"crossref","first-page":"pe24","DOI":"10.1126\/sageke.2005.31.pe24","article-title":"From bedside to bench: research agenda for frailty","volume":"2005","author":"Fried","year":"2005","journal-title":"Sci Aging Knowledge Environ"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0935","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/gerona\/glt011","article-title":"Impaired aerobic capacity and physical functional performance in older heart failure patients with preserved ejection fraction: role of lean body mass","volume":"68","author":"Haykowsky","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0940","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.amjcard.2013.12.031","article-title":"Skeletal muscle composition and its relationship to exercise intolerance in older patients with heart failure and preserved ejection fraction","volume":"113","author":"Haykowsky","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0945","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1152\/japplphysiol.00732.2011","article-title":"Regulation of subcutaneous adipose tissue blood flow during exercise in humans","volume":"112","author":"Heinonen","year":"2012","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0950","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1371\/journal.pmed.0040076","article-title":"Calorie restriction increases muscle mitochondrial biogenesis in healthy humans","volume":"4","author":"Civitarese","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0955","series-title":"Comprehensive Physiology","article-title":"Exercise: Kinetic Considerations for Gas Exchange","author":"Rossiter","year":"2010"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0960","doi-asserted-by":"crossref","first-page":"H1050","DOI":"10.1152\/ajpheart.00943.2011","article-title":"Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance","volume":"302","author":"Poole","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0965","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2012-3876","article-title":"Slow-Twitch Fiber Proportion in Skeletal Muscle Correlates With Insulin Responsiveness","volume":"98","author":"Stuart","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0970","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.CIR.81.2.518","article-title":"Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure","volume":"81","author":"Sullivan","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0975","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/01.CIR.84.4.1597","article-title":"Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity","volume":"84","author":"Sullivan","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0980","doi-asserted-by":"crossref","DOI":"10.1097\/00005768-199707000-00004","article-title":"Altered expression of myosin heavy chain in human skeletal muscle in chronic heart failure","volume":"29","author":"Sullivan","year":"1997","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0985","doi-asserted-by":"crossref","first-page":"E685","DOI":"10.1152\/ajpendo.00444.2004","article-title":"Skeletal muscle myofibrillar protein metabolism in heart failure: relationship to immune activation and functional capacity","volume":"288","author":"Toth","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0990","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1748-1716.1978.tb06187.x","article-title":"Histochemical and biochemical changes in human skeletal muscle with age in sedentary males, age 22-65 years","volume":"103","author":"Larsson","year":"1978","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb0995","doi-asserted-by":"crossref","first-page":"B71","DOI":"10.1093\/geronj\/47.3.B71","article-title":"Histochemical and enzymatic comparison of the gastrocnemius muscle of young and elderly men and women","volume":"47","author":"Coggan","year":"1992","journal-title":"J Gerontol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1000","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/CIRCHEARTFAILURE.109.898916","article-title":"A randomized, controlled, double-blinded trial of enalapril in older patients with heart failure and preserved ejection fraction; effects on exercise tolerance, and arterial distensibility","volume":"3","author":"Kitzman","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1005","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacc.2010.10.018","article-title":"Pentraxin 3 Is a New Inflammatory Marker Correlated With Left Ventricular Diastolic Dysfunction and Heart Failure With Normal Ejection Fraction","volume":"57","author":"Matsubara","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1010","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.12.045","article-title":"Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study","volume":"55","author":"Kalogeropoulos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1015","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/eurjhf\/hfr079","article-title":"Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?","volume":"13","author":"Collier","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1020","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1373\/clinchem.2010.159277","article-title":"Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction","volume":"57","author":"Shah","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1025","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging: An evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1030","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/CIRCHEARTFAILURE.111.963710","article-title":"Can Brain Natriuretic Peptide Be Used to Guide the Management of Patients With Heart Failure and a Preserved Ejection Fraction?: The Wrong Way to Identify New Treatments for a Nonexistent Disease","volume":"4","author":"Packer","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1035","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2012.04.064","article-title":"What Have We Learned About Patients With Heart Failure and Preserved Ejection Fraction From DIG-PEF, CHARM-Preserved, and I-PRESERVE?","volume":"60","author":"Campbell","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1040","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2012.11.027","article-title":"Risk Factors for Hospital Admission Among Older Persons With Newly Diagnosed Heart FailureFindings From the Cardiovascular Health Study","volume":"61","author":"Chaudhry","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1045","first-page":"835","article-title":"Prognostic implication of frailty and depressive symptoms in an outpatient population with heart failure","volume":"61","author":"Lupon","year":"2008","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1050","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0735-1097(02)01740-0","article-title":"Deconditioning fails to explain peripheral skeletal muscle alterations in men with chronic heart failure","volume":"39","author":"Duscha","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1055","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/01.RES.79.1.128","article-title":"Heart Failure in Rats Causes Changes in Skeletal Muscle Morphology and Gene Expression That Are Not Explained by Reduced Activity","volume":"79","author":"Simonini","year":"1996","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/gerona\/61.1.28","article-title":"Growth Hormone Replacement Attenuates Diastolic Dysfunction and Cardiac Angiotensin II Expression in Senescent Rats","volume":"61","author":"Groban","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1065","first-page":"3","article-title":"Progressive diastolic dysfunction in the female mRen(2). Lewis Rat: Influence of salt and ovarian hormones","volume":"63","author":"Groban","year":"2008","journal-title":"Gerontol B Physiol Sci Soc Sci"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00000542-200202000-00008","article-title":"Involvement of renin-angiotensin system in pressure-flow relationship: role of angiotensin-converting enzyme gene polymorphism","volume":"96","author":"Lasocki","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1075","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00005344-200402000-00019","article-title":"Effect of candesartan and verapamil on exercise tolerance in diastolic dysfunction","volume":"43","author":"Little","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1080","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1085","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1090","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.cardfail.2011.04.007","article-title":"Results of the Randomized Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction Trial (RAAM-PEF)","volume":"17","author":"Deswal","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1095","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jchf.2012.08.001","article-title":"Aldosterone antagonists and outcomes in real-world older patients with heart failure and preserved ejection fraction","volume":"1","author":"Patel","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an Aldosterone Antagonist (TOPCAT) Trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1105","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/eurjhf\/hfs141","article-title":"J-DHF Investigators. Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF)","volume":"1","author":"Yamamoto","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/eurjhf\/hfr161","article-title":"Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study","volume":"14","author":"Conraads","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jacc.2008.09.031","article-title":"Clinical Effectiveness of Beta-Blockers in Heart Failure: Findings From the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) Registry","volume":"53","author":"Hernandez","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/CIRCULATIONAHA.106.628347","article-title":"Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial","volume":"114","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1125","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jacc.2010.10.057","article-title":"Effects of Treatment on Exercise Tolerance, Cardiac Function, and Mortality in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis","volume":"57","author":"Holland","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1130","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: A randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1135","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1378\/chest.14-0106","article-title":"Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (dilate-1): A randomized, double-blind, placebo-controlled, single-dose study","volume":"146","author":"Bonderman","year":"2014","journal-title":"Chest J"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1140","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1161\/01.CIR.0000127939.16111.58","article-title":"Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice","volume":"109","author":"Hattori","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1145","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1440-1681.2005.04256.x","article-title":"In vitro inhibitory effects of atorvastatin on cardiac fibroblasts: implications for ventricular remodelling","volume":"32","author":"Martin","year":"2005","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1150","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.104.519876","article-title":"Statin Therapy May Be Associated With Lower Mortality in Patients With Diastolic Heart Failure: A Preliminary Report","volume":"112","author":"Fukuta","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1155","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.hfc.2008.01.005","article-title":"Observational studies of statins in heart failure with preserved systolic function","volume":"4","author":"Fukuta","year":"2008","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1160","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jacc.2013.06.043","article-title":"Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial","volume":"62","author":"Kosmala","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1165","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/CIRCHEARTFAILURE.112.969717","article-title":"Treating Anemia in Older Adults with Heart Failure with a Preserved Ejection Fraction (HFPEF) with Epoetin Alfa: Single Blind Randomized Clinical Trial of Safety and Efficacy","volume":"6","author":"Maurer","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1170","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cardfail.2004.09.010","article-title":"The Effect of Alagebrium Chloride (ALT-711), a Novel Glucose Cross-Link Breaker, in the Treatment of Elderly Patients with Diastolic Heart Failure","volume":"11","author":"Little","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1175","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/clc.20897","article-title":"Ranolazine for the Treatment of Heart Failure With Preserved Ejection Fraction: Background, Aims, and Design of the RALI-DHF Study","volume":"34","author":"Jacobshagen","year":"2011","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jchf.2012.12.002","article-title":"RAnoLazIne for the treatment of diastolic heart failure in patients with preserved ejection fraction: the RALI-DHF proof-of-concept study","volume":"1","author":"Maier","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1190","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jacc.2012.11.005","article-title":"Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the relaxin in acute heart failure (RELAX-AHF) development program: correlation with outcomes","volume":"61","author":"Metra","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1195","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/eurheartj\/eht497","article-title":"Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial","volume":"35","author":"Filippatos","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1200","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jchf.2013.12.002","article-title":"Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction","volume":"2","author":"Zile","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1205","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","article-title":"Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure","volume":"124","author":"Jessup","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCRESAHA.113.302421","article-title":"Long-term effects of AAV1\/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality","volume":"114","author":"Zsebo","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1215","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/cbic.200900666","article-title":"Strategies for the inhibition of protein aggregation in human diseases","volume":"11","author":"Bartolini","year":"2010","journal-title":"ChemBioChem"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1220","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.cardfail.2011.06.190","article-title":"Tafamidis stabilizes transthyretin and improves clinical outcomes in transthyretin amyloid cardiomyopathy","volume":"17","author":"Falk","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature04688","article-title":"RNAi-mediated gene silencing in non-human primates","volume":"441","author":"Zimmermann","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1230","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/mus.20503","article-title":"Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides","volume":"33","author":"Benson","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2015.01.009","article-title":"Hospitalizations and prognosis in elderly patients with heart failure and preserved ejection fraction: time to treat the whole patient","author":"Kitzman","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1240","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jacc.2011.06.054","article-title":"Exercise Training Improves Exercise Capacity and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction: Results of the Ex-DHF (Exercise training in Diastolic Heart Failure) Pilot Study","volume":"58","author":"Edelmann","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1245","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jacc.2013.04.033","article-title":"Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: A randomized, controlled, single-blind trial","volume":"62","author":"Kitzman","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1250","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.109.131110","article-title":"Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone\/salt-induced cardiac fibrosis and increased blood Pressure","volume":"54","author":"Rickard","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1255","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/01.HYP.0000215579.81408.8e","article-title":"Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction","volume":"47","author":"Klotz","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1260","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/HYPERTENSIONAHA.108.111815","article-title":"Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder","volume":"52","author":"Matsui","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1310","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/HYPERTENSIONAHA.112.202705","article-title":"Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction","volume":"60","author":"Hummel","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1265","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/CIRCHEARTFAILURE.113.000481","article-title":"Low-sodium DASH diet Improves diastolic function and ventricular-arterial coupling in hypertensive heart failure with preserved ejection fraction","volume":"6","author":"Hummel","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1270","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cardfail.2014.01.005","article-title":"Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure","volume":"20","author":"Kaye","year":"2014","journal-title":"J Card Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1275","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ejhf.111","article-title":"Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure","volume":"16","author":"Sondergaard","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1280","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cardfail.2010.09.004","article-title":"Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction","volume":"17","author":"Georgakopoulos","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1285","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"1919","journal-title":"Lancet"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1290","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/CIRCHEARTFAILURE.113.001229","article-title":"Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction","volume":"7","author":"Adamson","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1295","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jacc.2009.04.023","article-title":"Proof of concept: hemodynamic response to long-term partial ventricular support with the synergy pocket micro-pump","volume":"54","author":"Meyns","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.02.025_bb1300","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/eurjhf\/hfq068","article-title":"Cardiac resynchronization therapy for the causal treatment of heart failure with preserved ejection fraction: insight from a pressure-volume loop analysis","volume":"12","author":"Penicka","year":"2010","journal-title":"Eur J Heart Fail"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228281500070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228281500070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T14:36:01Z","timestamp":1566398161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002228281500070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":255,"alternative-id":["S002228281500070X"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2015.02.025","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart failure with preserved ejection fraction in the elderly: scope of the problem","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2015.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}